Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

Reig M, Mariño Z, Perelló C, et al. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. Iñarrairaegui M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, et al. J Hepatol. 2016;65(4):719-726.

Publication Type:

Journal Article

Authors:

Reig, María; Mariño, Zoe; Perelló, Christie; et, al

Source:

J Hepatol, Volume 65, Issue 4, p.719-726 (2016)

Keywords:

Direct-acting antivirals, HCV viral kinetics, hepatocellular carcinoma, Immune responses, Interferon-free regimen, Tumor recurrence

Cited On:

Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/27084592

Export Citation:

RIS Format

Top